Outlet track record
Oncology News Central
U.S. specialty medical trade
Oncology News Central is a digital trade publication for cancer care professionals, owned by HealthCentral Corporation and backed by the private equity firm Amulet Capital Partners. Its content focuses on clinical oncology news, drug approvals, and practice management rather than politics. It does not take discernible positions on the Trump administration, as its editorial scope is narrowly medical and professional.
Owned byHealthCentral Corporation, itself owned by Amulet Capital Partners, a healthcare-focused private equity firm
LeaningU.S. specialty medical trade
On the administrationmostly neutral
5average bias score across 1 story
1 = straight reporting · 10 = heavily spun
1 = straight reporting · 10 = heavily spun